Literature DB >> 25747728

Oxidative stress as common trait of endothelial dysfunction in chorionic arteries from fetuses with IUGR and LGA.

D Schneider1, C Hernández2, M Farías1, R Uauy3, B J Krause1, P Casanello4.   

Abstract

INTRODUCTION: Fetal macrosomia and intrauterine growth restriction (IUGR) associate with increased morbidity in the neonate. Placental vascular relaxation is impaired in fetal macrosomia, as well as in IUGR, and this could result from increased oxidative stress present in both conditions. We determined the role of pro- and anti-oxidants on NOS dependent relaxation in placental chorionic arteries from pregnancies with LGA babies from overweight and/or obese mothers (LOOM) and IUGR fetuses from normal BMI women.
METHODS: Chorionic arteries were mounted in a wire-myograph, where responses to the NOS-dependent agent CGRP in presence or absence of the antioxidant N-acetyl cysteine (NAC), the pro-oxidant SIN-1, the SOD inhibitor DDC, and the GPx inhibitor MS were determined. Additionally the presence of pro- and antioxidant enzymes (NOX-4, SOD-1, SOD-2 and GPx-1) and eNOS in chorionic and umbilical vessels were addressed by immunohistochemistry.
RESULTS: Maximal CGRP-induced relaxation was comparable to controls but presented a reduced potency in chorionic arteries from LOOM placentae, whilst in IUGR vessels both maximal response and potency were reduced. NAC increased maximal relaxation in controls, IUGR and LOOM arteries, whilst SIN-1 completely abolished the CGRP-induced relaxation only in IUGR and LOOM samples, the later effect was paralleled by SOD or GPx inhibition. These responses associated with the presence of NOX-4, SOD-1 and GPx-1 in the endothelium and vascular wall of chorionic and umbilical arteries in the different groups studied. DISCUSSION: These data suggest that NOS dependent relaxation in placental vessels from IUGR and LOOM pregnancies present a higher sensitivity to oxidative stress.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endothelial function; IUGR; LGA; Maternal obesity; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25747728     DOI: 10.1016/j.placenta.2015.02.003

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  13 in total

1.  N-Acetylcysteine, a glutathione precursor, reverts vascular dysfunction and endothelial epigenetic programming in intrauterine growth restricted guinea pigs.

Authors:  Emilio A Herrera; Francisca Cifuentes-Zúñiga; Esteban Figueroa; Cristian Villanueva; Cherie Hernández; René Alegría; Viviana Arroyo-Jousse; Estefania Peñaloza; Marcelo Farías; Ricardo Uauy; Paola Casanello; Bernardo J Krause
Journal:  J Physiol       Date:  2016-12-04       Impact factor: 5.182

Review 2.  Programming of maternal and offspring disease: impact of growth restriction, fetal sex and transmission across generations.

Authors:  Jean N Cheong; Mary E Wlodek; Karen M Moritz; James S M Cuffe
Journal:  J Physiol       Date:  2016-04-24       Impact factor: 5.182

3.  Identification of maternal continuous glucose monitoring metrics related to newborn birth weight in pregnant women with gestational diabetes.

Authors:  Song-Ying Shen; Justina Žurauskienė; Dong-Mei Wei; Nian-Nian Chen; Jin-Hua Lu; Ya-Shu Kuang; Hui-Hui Liu; Jean-Baptiste Cazier; Xiu Qiu
Journal:  Endocrine       Date:  2021-06-14       Impact factor: 3.633

Review 4.  Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period.

Authors:  Marta Perez; Mary E Robbins; Cecilie Revhaug; Ola D Saugstad
Journal:  Free Radic Biol Med       Date:  2019-04-05       Impact factor: 7.376

5.  Impaired Vasodilatory Responses of Omental Arteries to CGRP Family Peptides in Pregnancies Complicated by Fetal Growth Restriction.

Authors:  Madhu Chauhan; Ancizar Betancourt; Meena Balakrishnan; Uma Yallampalli; Yuanlin Dong; Karin Fox; Michael Belfort; Chandra Yallampalli
Journal:  J Clin Endocrinol Metab       Date:  2016-06-03       Impact factor: 5.958

6.  Oxidative Stress Markers Differ in Two Placental Dysfunction Pathologies: Pregnancy-Induced Hypertension and Intrauterine Growth Restriction.

Authors:  Aleksandra Zygula; Przemyslaw Kosinski; Piotr Wroczynski; Magdalena Makarewicz-Wujec; Bronislawa Pietrzak; Mirosław Wielgos; Joanna Giebultowicz
Journal:  Oxid Med Cell Longev       Date:  2020-06-30       Impact factor: 6.543

7.  Nox2 impairs VEGF-A-induced angiogenesis in placenta via mitochondrial ROS-STAT3 pathway.

Authors:  Chengjun Hu; Zifang Wu; Zihao Huang; Xiangyu Hao; Shuqi Wang; Jinping Deng; Yulong Yin; Chengquan Tan
Journal:  Redox Biol       Date:  2021-06-18       Impact factor: 11.799

8.  Changes in Copper, Zinc, and Malondialdehyde Levels and Superoxide Dismutase Activities in Pre-Eclamptic Pregnancies.

Authors:  Murat Bakacak; Metin Kılınç; Salih Serin; Önder Ercan; Bülent Köstü; Fazıl Avcı; Hakan Kıran; Gürkan Kıran
Journal:  Med Sci Monit       Date:  2015-08-17

9.  Maternal fructose drives placental uric acid production leading to adverse fetal outcomes.

Authors:  Zeenat A Asghar; Alysha Thompson; Maggie Chi; Andrew Cusumano; Suzanne Scheaffer; Noor Al-Hammadi; Jessica L Saben; Kelle H Moley
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

10.  Developmental origins of metabolic disorders: The need for biomarker candidates and therapeutic targets from adequate preclinical models.

Authors:  Antonio Gonzalez-Bulnes; Susana Astiz; Marta Vazquez-Gomez; Consolación Garcia-Contreras
Journal:  EuPA Open Proteom       Date:  2016-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.